Mutant MHC Class II Epitopes Drive Therapeutic Immune Responses to Cancer

Nature - United Kingdom
doi 10.1038/nature14426
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Soluble MHC Molecules in Immune Regulation: Highlighting Class II Antigens

Immunology
AllergyImmunology
2017English

Evolutionary Pressure Against MHC Class II Binding Cancer Mutations

Cell
BiochemistryGeneticsMolecular Biology
2018English

Mice Lacking the MHC Class II Transactivator (CIITA) Show Tissue-Specific Impairment of MHC Class II Expression

Immunity
Infectious DiseasesAllergyImmunology
1996English

Diversity of Bovine MHC Class II Gene

The Journal of Animal Genetics
2014English

Design of Glycopeptides Used to Investigate Class II MHC Binding and T-Cell Responses Associated With Autoimmune Arthritis

PLoS ONE
Multidisciplinary
2011English

Herpes Simplex Virus Type 1 Targets the MHC Class II Processing Pathway for Immune Evasion

Journal of Immunology
AllergyImmunology
2003English

Promiscuity of MHC Class Ib-Restricted T Cell Responses

Journal of Immunology
AllergyImmunology
2003English

Front Cover: Building Proteomic Tool Boxes to Monitor MHC Class I and Class II Peptide

Proteomics
BiochemistryMolecular Biology
2017English

CCR5 Is Required for Regulation of Alloreactive T-Cell Responses to Single Class II MHC-Mismatched Murine Cardiac Grafts

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy